NCT00335036

Brief Summary

This is a randomized, prospective clinical trial comparing 2 different types of implantable cardioverter defibrillator (ICD) leads in children and patients with congenital heart disease. ICD lead survival in this patient group is particularly suboptimal, and lead extraction is technically difficult and carries a substantial morbidity risk. Recently, improved ICD lead designs have been released and are currently being utilized in patients. The main aim of the study is to determine if either type of lead performs better in terms of implantation electrical characteristics, long-term survival without breaking, and ease of extractability.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
748

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2006

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2006

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

June 6, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 8, 2006

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2009

Completed
16.6 years until next milestone

Results Posted

Study results publicly available

July 17, 2025

Completed
Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

2.6 years

First QC Date

June 6, 2006

Results QC Date

April 1, 2019

Last Update Submit

March 17, 2026

Conditions

Keywords

Implantable Cardioverter DefibrillatorVentricular ArrhythmiaSudden Cardiac DeathCongenital Heart DiseasePediatric Electrophysiology

Outcome Measures

Primary Outcomes (2)

  • ICD Lead Functionality and Performance by Subtype

    Lead survival

    5 years

  • Compare Ease of Lead Extractability by Subtype

    Extraction techniques include simple traction (no locking stylet or sheath) and advanced extraction (locking stylet with a sheath). Compared number of extractions using each technique for single and ePTFE-coated coils.

    5 years

Secondary Outcomes (2)

  • Number of Patients With Major Complications

    5 years

  • Comparison of Inappropriate Shocks

    5 years

Study Arms (2)

Thin leads

ACTIVE COMPARATOR

Thin (less than or equal to 7 French introducer) isodiametric ICD leads

Device: Thin leads

Gore PTFE-coated

ACTIVE COMPARATOR

ICD lead with PTFE-coated coils

Device: ICD lead implant

Interventions

Randomization of ICD lead type at implant

Gore PTFE-coated

Thin (less than or equal to 7 French introducer) isodiametric ICD leads

Thin leads

Eligibility Criteria

Age1 Year - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients will be eligible for study enrollment at the time of implantation of a new ICD and transvenous ICD lead.
  • All patients under the age of 21 years at the time of initial ICD implantation, or those patients with congenital heart disease and an indication for ICD implantation are eligible for participation.

You may not qualify if:

  • Patients who have existing ICD leads in place.
  • Patients with expected survival less than 1 year.
  • Patients who cannot be expected to participate in follow-up visits.
  • Patients receiving an epicardial or subcutaneous ICD (without transvenous ICD lead).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital Boston

Boston, Massachusetts, 02115, United States

Location

Related Publications (5)

  • Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol. 2004 Jan;15(1):72-6. doi: 10.1046/j.1540-8167.2004.03388.x.

    PMID: 15028076BACKGROUND
  • Stephenson EA, Batra AS, Knilans TK, Gow RM, Gradaus R, Balaji S, Dubin AM, Rhee EK, Ro PS, Thogersen AM, Cecchin F, Triedman JK, Walsh EP, Berul CI. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2006 Jan;17(1):41-6. doi: 10.1111/j.1540-8167.2005.00271.x.

    PMID: 16426398BACKGROUND
  • Cooper JM, Stephenson EA, Berul CI, Walsh EP, Epstein LM. Implantable cardioverter defibrillator lead complications and laser extraction in children and young adults with congenital heart disease: implications for implantation and management. J Cardiovasc Electrophysiol. 2003 Apr;14(4):344-9. doi: 10.1046/j.1540-8167.2003.02500.x.

    PMID: 12741703BACKGROUND
  • Link MS, Hill SL, Cliff DL, Swygman CA, Foote CB, Homoud MK, Wang PJ, Estes NA 3rd, Berul CI. Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am J Cardiol. 1999 Jan 15;83(2):263-6, A5-6. doi: 10.1016/s0002-9149(98)00834-0.

    PMID: 10073833BACKGROUND
  • Atallah J, Erickson CC, Cecchin F, Dubin AM, Law IH, Cohen MI, Lapage MJ, Cannon BC, Chun TU, Freedenberg V, Gierdalski M, Berul CI; Pediatric and Congenital Electrophysiology Society (PACES). Multi-institutional study of implantable defibrillator lead performance in children and young adults: results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) study. Circulation. 2013 Jun 18;127(24):2393-402. doi: 10.1161/CIRCULATIONAHA.112.001120. Epub 2013 May 21.

MeSH Terms

Conditions

Tachycardia, VentricularVentricular FibrillationCardiomyopathiesLong QT SyndromeHeart Defects, CongenitalDeath, Sudden, Cardiac

Condition Hierarchy (Ancestors)

TachycardiaArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and SymptomsCardiovascular AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHeart ArrestDeath, SuddenDeath

Results Point of Contact

Title
Charles Berul, MD
Organization
Children's National

Study Officials

  • Charles I Berul, MD

    Boston Children's Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Open label
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

June 6, 2006

First Posted

June 8, 2006

Study Start

June 1, 2006

Primary Completion

January 1, 2009

Study Completion

January 1, 2009

Last Updated

March 19, 2026

Results First Posted

July 17, 2025

Record last verified: 2026-03

Locations